ֱ

Stop Calling It Cancer; AI Gets a Win in Bladder Cancer; Lack of Price Transparency

— News, features, and commentary about cancer-related issues

MedpageToday
Cancer cells with OncoBreak in the center.

A group of prostate cancer specialists, joined by ֱ contributor and prostate cancer patient Howard Wolinsky, made a case to stop referring to (Gleason ≤6) as cancer. (Journal of Clinical Oncology)

The issued a statement in support of efforts to reduce harmful environmental emissions, improve air quality, and conduct more research into the relationship between air pollution and lung cancer.

Break Through Cancer announced $50 million in grant support for a involving investigators at five major research centers.

In preclinical studies, (histotripsy) partly destroyed tumors and activated the immune system to prevent the cancer from returning. (University of Michigan, Cancers)

A blood test showed early promise as a potential . (Advanced NanoBiomed Research)

William Dahut, MD, formerly of the National Cancer Institute's (NCI) Center for Cancer Research, has joined the American Cancer Society as .

Could an FDA proposal to ban menthol-flavored cigarettes have the unintended consequence of , which have lower quit rates and a closer association with lung cancer? (Vanderbilt University Medical Center, Journal of the National Cancer Institute)

Using to guide treatment for glioblastoma led to an 8-month improvement in median survival. (University of California San Francisco, Neuro-Oncology)

Another good look for , this time for assessing response to chemotherapy before bladder cancer surgery. (University of Michigan, Tomography)

A study of 61 NCI-designated cancer centers showed large and widely varying for therapies and a general lack of transparency in the pricing of services. (Brigham & Women's Hospital, JAMA Internal Medicine)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined ֱ in 2007.